DAX23.739 +0,9%ESt505.500 +1,0%Top 10 Crypto15,32 +0,4%Dow46.247 +0,7%Nas22.484 +0,4%Bitcoin93.424 -0,3%Euro1,1704 ±0,0%Öl69,75 +0,2%Gold3.763 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Lufthansa 823212 NVIDIA 918422 DroneShield A2DMAA Novo Nordisk A3EU6F Tesla A1CX3T RENK RENK73 Allianz 840400 HENSOLDT HAG000 Amazon 906866 Deutsche Telekom 555750 BASF BASF11 SAP 716460 Volkswagen (VW) vz. 766403 Siemens Energy ENER6Y
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach US-Inflationsdaten: DAX geht höher ins Wochenende -- US-Börsen fest -- Höhere Trump-Zölle auf Arzneimittel & Co. -- Gerresheimer, Intel, Plug Power, Siemens, Rheinmetall, D-Wave, Oracle im Fokus
Top News
So finden Anleger das passende Risikoprofil für ihre Geldanlage So finden Anleger das passende Risikoprofil für ihre Geldanlage
Bilanzen und Termine: Tesla, NVIDIA, Apple, Amazon & Co. - Ergebnisse der Tech-Riesen in der aktuellen Saison Bilanzen und Termine: Tesla, NVIDIA, Apple, Amazon & Co. - Ergebnisse der Tech-Riesen in der aktuellen Saison
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Jetzt 3-fach-Bonus sichern bei finanzen.net zero und dauerhaft Gebühren sparen!

Poxel SA Aktie

Kaufen
Verkaufen
Poxel SA Aktien-Sparplan
0,2980 EUR -0,0090 EUR -2,93 %
BMN
0,3100 EUR -0,0030 EUR -0,96 %
PAR
Poxel SA jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.15,90 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA14M04

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINFR0012432516

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPXXLF

Poxel SA Aktien News

DatumMeistgelesen
BusinesswirePoxel Reports Financial Results for First Half 2024 and Provides an Update on its Financial Position and Outlook
BusinesswirePoxel Reports Cash and Revenue for the Third Quarter and Nine Months 2024 and Provides Corporate Update
BusinesswirePoxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million
Wer­bungPoxel SA-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BusinesswirePoxel Reports Revenue for the Second Quarter and First Half 2024 and Provides Corporate Update
BusinesswireSumitomo Pharma and Poxel Announce Topline Results from Post-Marketing Clinical Study on TWYMEEG® for the Treatment of Type 2 Diabetes in Japan
BusinesswirePoxel Provides an Update on Its Financial Position for the Second Quarter and First Half of 2024 and Announces the Rescheduling of Its Annual General Meeting
BusinesswirePoxel Reports Revenue for the First Quarter 2024 and Provides Corporate Update
BusinesswirePoxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release
BusinesswirePoxel to Report Its 2023 Annual Results by the End of April 2024
BusinesswirePoxel Reports Cash and Revenue for the Full Year 2023 and Provides Corporate Update
BusinesswirePoxel Announces its Financial Calendar for 2024
BusinesswirePoxel Provides Corporate Update
BusinesswirePoxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023
BusinesswirePoxel Announces its Participation at Upcoming Investor Conferences
BusinesswirePoxel Announces its Participation at Upcoming Scientific Conference
BusinesswirePoxel Reports Financial Results for First Half 2023 and Provides a Corporate Update
BusinesswirePoxel to Report 2023 First Half-Year Results and host a video conference on September 26, 2023
BusinesswirePoxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update
BusinesswirePoxel Announces Upcoming Participation at the H.C. Wainwright 2nd Annual Kidney Conference
BusinesswirePoxel, winner of the 2023 edition of the I-nov contest
BusinesswirePoxel Announces the Approval of a Prospectus for the Listing of New Shares on Euronext Paris
BusinesswirePoxel Announces Results from June 21, 2023 Ordinary Annual and Extraordinary General Meeting
BusinesswirePoxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy
BusinesswirePoxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update
BusinesswirePoxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2023
BusinesswirePoxel Announces TWYMEEG® (Imeglimin) Fiscal Year 2022 Sales
BusinesswirePoxel Announces Upcoming Participation at the JMP Securities Life Science Conference
BusinesswirePoxel Announces Multiple TWYMEEG® (Imeglimin) Abstracts Accepted for Oral Presentation
BusinesswirePoxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility
BusinesswirePoxel Reports Financial Results for Full Year 2022 and Provides Corporate Update
BusinesswirePoxel Announces Upcoming Participation at Evercore ISI’s NASH Renaissance Event
BusinesswirePoxel Announces Publication of Positive Phase 2 Results from Phase 2 NASH Trial (DESTINY-1) for PXL065 in Journal of Hepatology
BusinesswirePoxel Announces Publication in Kidney International of PXL770 Preclinical Results in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
BusinesswirePoxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update
BusinesswirePoxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy
BusinesswirePoxel Announces its Financial Calendar for 2023
BusinesswirePoxel Announces Drawdown of the Remaining Two Tranches of its Equity-linked Financing Facility and Provides Corporate Update
BusinesswirePoxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2022
BusinesswirePoxel Presents DESTINY-1 Phase 2 Results for PXL065 in NASH at AASLD The Liver Meeting® 2022
BusinesswirePoxel Announces Upcoming Participation at the Jefferies London Healthcare Conference

Poxel SA News

Poxel SA News: auf dieser Seite finden Sie alle Poxel SA News und Nachrichten zur Poxel SA Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Poxel SA News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Poxel SA News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.